The American Herbal Products Association (AHPA; Silver Spring, MD) supported the FDA’s efforts to recall products marketed as dietary supplements that contained undeclared, active pharmaceutical ingredients, AHPA said on January 9.
Responding to recent statements regarding dietary supplement regulation, the Natural Products Association’s (NPA; Washington, DC) CEO, David Seckman, released this statement on January 8:“Increased scrutiny by professional sports leagues on steroid usage, which the NPA commends, has unfortunately also led to increased and unsubstantiated allegations that a "tainted" or mislabeled dietary supplement is to blame when an athlete tests positive for a banned substance.
In a new study, Fuji Health’s (Burlington, NJ) brand of natural astaxanthin extract (AstaREAL) derived from Haematococcus microalgae was detected in the iris/ciliary body of New Zealand albino rabbit eyes 24 hours after ingestion, the company announced on January 6.
Aloha Medicinals (Carson City, NV) announced the construction of a second proprietary nanoparticle manufacturing device, the company said on January 6. Aloha first introduced nano-sized medicinal mushroom products in early 2008.
Responding to the growing popularity of a plant-based sweetener, the U.S. Pharmacopeial (USP; Rockville, MD) Convention today announced it is developing a new standard to be included in the Food Chemicals Codex (FCC) that will help food and beverage manufacturers assure the product’s quality for consumers.
Sabinsa’s (Piscataway, NJ) probiotic ingredient, LactoSpore, received GRAS status after a review of safety and toxicology data by an independent panel of scientists.
TensGuard, an odorless, water soluble blood pressure management ingredient from DSM Nutritional Products (Parsippany, NJ), was recently awarded first prize at this year’s Health Ingredients Europe exhibition by a judging panel of retailers, manufacturers, scientists, and industry leaders.
On November 21, FTC announced that it is seeking public comments on proposed revisions to the Guides Concerning the Use of Endorsements and Testimonials in Advertising. The proposed revisions are intended to ensure that testimonials describe typical consumer experiences. FTC will stop accepting public comments on January 30, 2009. Nutritional Outlook spoke with John Feldman, a partner at Reed Smith LLP (Washington, DC), about the proposed changes.
Why is FTC considering making changes to the guides?
OmniActive Health Technologies (Short Hills, NJ) announced the launch of a proprietary blend of Capsimax Plus, its capsicum, or hot red pepper, ingredient, on December 18.
In a study released on December 18, Scientia (Palo Alto, CA) predicts an annual compound growth rate of 7% through 2012, averaged across all segments of the industry.
BASF Corp. (Wilmington, NC) announced on December 18 that it will close its Wilmington, NC, vitamins manufacturing site by March 31, 2009.
FDA issued a “no objection” letter to the GRAS status of rebaudioside A (Reb A), the stevia extract used in PureVia, PepsiCo’s (Purchase, NY) all-natural, zero-calorie sweetener, PepsiCo announced on December 17.
The American Herbal Products Association (AHPA; Silver Spring, MD) has petitioned U.S. Pharmacopeia (USP; Rockville, MD) to adopt AHPA’s guidance limits for heavy metals in “orally consumed botanical-containing finished products,” AHPA announced on December 16.
Nutraceutix (Redmond, WA) received a patent for BIO-tract from the Australian Patent Office. BIO-tract tablets form a protective layer in the body, shielding probiotic organisms from the acidic conditions of the stomach. After passing from the stomach to the intestinal tract, the tablets release the organisms at rates determined by formulation.
A $7 million settlement has been reached between Airborne Health Inc. (Minneapolis), Florida, and 31 other states, said Florida Attorney General Bill McCollum on December 16.